Carregant...
Nanotechnology applications in hematological malignancies (Review)
A major limitation to current cancer therapies is the development of therapy-related side-effects and dose limiting complications. Moreover, a better understanding of the biology of cancer cells and the mechanisms of resistance to therapy is rapidly developing. The translation of advanced knowledge...
Guardat en:
| Publicat a: | Oncol Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530900/ https://ncbi.nlm.nih.gov/pubmed/26134389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2015.4100 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|